4
Changes in Ownership
Iambic Therapeutics, Inc. Filed Acc 0001205903-26-000013
Director acquired 200,920 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| RASTETTER WILLIAM H Director | 2026-10-16 | Conversion | +192,579 | 192,579 | I | ||
| RASTETTER WILLIAM H Director | 2026-10-16 | Conversion | +8,341 | 200,920 | I | ||
| Derivatives | |||||||
| RASTETTER WILLIAM H Director | 2026-10-16 | Conversion · Series B Convertible Preferred Stock | −76,801 | 0 | I | ||
| RASTETTER WILLIAM H Director | 2026-10-16 | Conversion · Series B-2 Convertible Preferred Stock | −64,001 | 0 | I | ||
| RASTETTER WILLIAM H Director | 2026-10-16 | Conversion · Series B-3 Convertible Preferred Stock | −36,805 | 0 | I | ||
| RASTETTER WILLIAM H Director | 2026-10-16 | Conversion · Series B-4 Convertible Preferred Stock | −14,972 | 0 | I | ||
| RASTETTER WILLIAM H Director | 2026-10-16 | Conversion · Convertible Promissory Notes | −8,341 | 0 | I | ||
Loading xslF345X06/form4-10192026_111025.xml…